Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | UGT2A3 |
| Upstream (Parents) |
|---|
| (<<) SERPINA5 → UGT2A3 |
| (<<) AGT → UGT2A3 |
| (<<) PDZK1 → UGT2A3 |
| (<<) DEFB1 → UGT2A3 |
| (<<) ENTPD5 → UGT2A3 |
| Downstream (Children) |
|---|
| UGT2A3 → CALB1 (>>) |
| UGT2A3 → HAPLN1 (>>) |
| UGT2A3 → AKR1B10 (>>) |
| UGT2A3 → CXCL6 (>>) |
| UGT2A3 → EPN2 (>>) |
| UGT2A3 → AAK1 (>>) |
| UGT2A3 → CAPZB (>>) |
